We are live on ! Find out more
PAVMZ

PAVmed Inc. Series Z Warrant

Delisted

PAVMZ was delisted on the 30th of April, 2025.

7 hedge funds and large institutions have $1.34M invested in PAVmed Inc. Series Z Warrant in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $1.14M → $1.34M (+$200K)

0% more funds holding

Funds holding: 77 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
7
Holders Change
Holders Change %
0%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
1
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$962K -$891K -1,117,323 -52%
LCS
2
Levin Capital Strategies
New York
$306K -$279K -350,000 -52%
ICM
3
Ionic Capital Management
New York
$72K +$61.5K +77,066 New
Bank of America
4
Bank of America
North Carolina
$1K
MRCM
5
M&R Capital Management
New Jersey
-$32K -83,335 Closed
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
-$9K -23,195 Closed
UBS Group
7
UBS Group
Switzerland
+$229 +287 +141%
TWA
8
TCI Wealth Advisors
Arizona
+$239 +300 New

PAVMZ Hedge Fund Activity: Q1 2020 in Review

7 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q1 2020, worth a combined $1.34M — up 18% from $1.14M a quarter earlier.

Fund positioning in PAVMZ was balanced in Q1 2020: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Ionic Capital Management, opening a new position worth an estimated $61.5K. The largest seller was Sabby Management, cutting an estimated $891K.

  • 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q1 2020, unchanged from Q4 2019.
  • Funds reported $1.34M of PAVmed Inc. Series Z Warrant stock for Q1 2020, up 18% quarter-over-quarter.
  • 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q1 2020 and 2 closed out, a net change of 0 holders.
  • The largest PAVmed Inc. Series Z Warrant buyer in Q1 2020 was Ionic Capital Management, an estimated $61.5K added.
  • The largest PAVmed Inc. Series Z Warrant seller in Q1 2020 was Sabby Management, an estimated $891K sold.

Based on aggregated 13F filings for Q1 2020.